...
首页> 外文期刊>Diabetologia >In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver
【24h】

In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver

机译:人体血管内皮生长因子的体内非病毒基因传递改善了人类胰岛移植到小鼠肝脏后的血运重建和血糖的恢复

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims/hypothesis Delivery of the gene for human vascular endothelial growth factor (VEGF, also known as VEGFA) to both the transplanted islets and the surrounding tissue may promote islet revascularisation and survival. We previously showed the effective delivery of VEGF gene to rat myocardium by an ultrasound-mediated gene-transfer method named ultrasound-targeted microbubble destruction (UTMD). Here we examined the effect of non-viral VEGF delivery using UTMD on transplanted islets in vivo.
机译:目的/假设将人类血管内皮生长因子(VEGF,也称为VEGFA)的基因同时递送至移植的胰岛和周围组织可能会促进胰岛的血运重建和生存。我们以前通过称为超声靶向微泡破坏(UTMD)的超声介导的基因转移方法展示了VEGF基因向大鼠心肌的有效递送。在这里,我们检查了使用UTMD进行的非病毒VEGF递送对体内胰岛的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号